Hao Tang

ORCID: 0000-0003-2202-0515
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Lung Cancer Treatments and Mutations
  • Cancer Immunotherapy and Biomarkers
  • Lung Cancer Diagnosis and Treatment
  • Aortic Disease and Treatment Approaches
  • Aortic aneurysm repair treatments
  • Cardiac Valve Diseases and Treatments
  • Cancer Genomics and Diagnostics
  • Radiomics and Machine Learning in Medical Imaging
  • Ferroptosis and cancer prognosis
  • Cancer-related molecular mechanisms research
  • RNA modifications and cancer
  • Abdominal Surgery and Complications
  • Renal cell carcinoma treatment
  • CAR-T cell therapy research
  • Lung Cancer Research Studies
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Infectious Aortic and Vascular Conditions
  • Hernia repair and management
  • Immunotherapy and Immune Responses
  • Extracellular vesicles in disease
  • Monoclonal and Polyclonal Antibodies Research
  • interferon and immune responses
  • MRI in cancer diagnosis
  • Pancreatic and Hepatic Oncology Research
  • Venous Thromboembolism Diagnosis and Management

Central South University
2016-2025

Second Xiangya Hospital of Central South University
2014-2025

Nanjing Medical University
2024-2025

The First People’s Hospital of Lianyungang
2021-2025

Wuhan University
2023-2025

Shanghai Jiao Tong University
2022-2025

Kangda College of Nanjing Medical University
2025

Xuzhou Medical College
2022-2025

Songjiang District Central Hospital
2025

Xiangya Hospital Central South University
2013-2024

Nivolumab, a programmed death (PD)-1 (PD-1) inhibitor, led to durable responses, manageable safety, and increased survival in patients with advanced hepatocellular carcinoma (HCC). In our retrospective analysis, we studied the immunobiology potential associations between biomarkers outcomes nivolumab HCC.Fresh archival tumour samples from dose-escalation dose-expansion phases of CheckMate 040 trial were analysed by immunohistochemistry RNA sequencing assess several inflammatory gene...

10.1016/j.jhep.2020.07.026 article EN cc-by-nc-nd Journal of Hepatology 2020-07-22

To date, estrogen is the only known endogenous receptor (ER) ligand that promotes ER+ breast tumor growth. We report cholesterol metabolite 27-hydroxycholesterol (27HC) stimulates MCF-7 cell xenograft growth in mice. More importantly, cancer patients, 27HC content normal tissue increased compared to cancer-free controls, and further elevated. Increased correlated with diminished expression of CYP7B1, metabolizing enzyme, reduced CYP7B1 tumors associated poorer patient survival. Moreover,...

10.1016/j.celrep.2013.10.006 article EN cc-by-nc-nd Cell Reports 2013-11-01

Inflammatory mediators, including acute phase reactants and cytokines, have been reported to be associated with clinical efficacy in patients melanoma other cancers receiving immune checkpoint inhibitors (ICI). Analyses of patient sera from three large II/III randomized ICI trials, one which included a chemotherapy arm, were performed assess whether baseline levels C-reactive protein (CRP), interleukin-6 (IL-6) or neutrophil/lymphocyte (N/L) ratios prognostic predictive.Baseline on-treatment...

10.1136/jitc-2020-000842 article EN cc-by-nc Journal for ImmunoTherapy of Cancer 2020-06-01

Ipilimumab and nivolumab have each shown treatment benefit for high-risk resected melanoma. The phase III CheckMate 915 trial evaluated adjuvant plus ipilimumab versus alone in patients with stage IIIB-D or IV melanoma.In this randomized, double-blind, trial, 1,833 received 240 mg once every 2 weeks 1 mg/kg 6 (916 patients) 480 4 (917 ≤ year. After random assignment, were stratified by tumor programmed death ligand (PD-L1) expression stage. Dual primary end points recurrence-free survival...

10.1200/jco.22.00533 article EN cc-by-nc-nd Journal of Clinical Oncology 2022-09-26

Open-label phase II study (RELATIVITY-060) to investigate the efficacy and safety of first-line nivolumab, a PD-1-blocking antibody, plus relatlimab, lymphocyte-activation gene 3 (LAG-3)-blocking chemotherapy in patients with previously untreated advanced gastric cancer (GC) or gastroesophageal junction (GEJC).

10.1200/jco.23.01636 article EN Journal of Clinical Oncology 2024-05-09

Abstract: Regeneration deficiency is one of the main obstacles limiting effectiveness tissue-engineered scaffolds. To develop scaffolds that are capable accelerating regeneration, we created a heparin/chitosan nanoparticle-immobilized decellularized bovine jugular vein scaffold to increase loading capacity and allow for controlled release vascular endothelial growth factor (VEGF). The vascularization was evaluated in vitro vivo. functional nanoparticles were prepared by physical...

10.2147/ijn.s18753 article EN cc-by-nc International Journal of Nanomedicine 2011-05-01

Background Information: Previous studies have revealed that leptin may be involved in epithelial-mesenchymal transition (EMT), a crucial initiator of cancer progression to facilitate metastatic cascade, increase tumor recurrence, and ultimately cause poor prognosis. However, the underlying mechanism remains unclear. The aim our present study was investigate effect on EMT breast cells mechanism. Results: Our data demonstrated significantly increased phosphorylation STAT3, Akt, ERK1/2,...

10.1080/15384047.2015.1056409 article EN Cancer Biology & Therapy 2015-06-29

Abstract Outcomes for patients with melanoma have improved over the past decade as a result of development and FDA approval immunotherapies targeting cytotoxic T lymphocyte antigen-4 (CTLA-4), programmed death-1 (PD-1), death ligand 1 (PD-L1). However, these therapies do not benefit all patients, an area intensive research investigation is identifying biomarkers that can predict which are most likely to from them. Here, we report exploratory analyses associations tumor mutational burden...

10.1158/2326-6066.cir-20-0983 article EN cc-by-nc-nd Cancer Immunology Research 2021-08-13

Abstract Background Coronavirus disease (COVID-19) has become a pandemic. The knowledge, attitudes, and practices (KAP) of the public play major role in prevention control infectious diseases. objective present study was to evaluate KAP Chinese assess potential influencing factors related practices. Methods A cross-sectional online survey conducted China February 2020 via self-designed questionnaire comprising 33 questions assessing KAP. Results For 2136 respondents from 30 provinces or...

10.1186/s12889-020-09961-2 article EN cc-by BMC Public Health 2020-11-30

Abstract The development of strain sensors with high stretchability and stability is an inevitable requirement for achieving full‐range long‐term use wearable electronic devices. Herein, a resistive micromesh reinforced sensor (MRSS) prepared, consisting laser‐scribed graphene (LSG) layer two styrene‐block‐poly(ethylene‐ran‐butylene)‐block‐poly‐styrene layers embedded in Ecoflex. structure endows the MRSS combined characteristics (120%), excellent (with repetition error 0.8% after 11 000...

10.1002/inf2.12511 article EN cc-by InfoMat 2024-03-04

Quantitative high-throughput screening (qHTS) assays are increasingly being used to inform chemical hazard identification. Hundreds of chemicals have been tested in dozens cell lines across extensive concentration ranges by the National Toxicology Program collaboration with Institutes Health Chemical Genomics Center.Our goal was test a hypothesis that dose-response data points qHTS can serve as biological descriptors assayed and, when combined conventional descriptors, improve accuracy...

10.1289/ehp.1002476 article EN public-domain Environmental Health Perspectives 2010-10-27
Solveig K. Sieberts Fan Zhu Javier Garcı́a-Garcı́a Eli A. Stahl Abhishek Pratap and 95 more Gaurav Pandey Dimitrios A. Pappas Daniel Aguilar Bernat Anton Jaume Bonet Ridvan Eksi Oriol Fornés Emre Güney Hongdong Li Manuel Alejandro Marín-López Bharat Panwar Joan Planas-Iglesias Daniel Poglayen Jing Cui André O. Falcão Christine Suver Bruce Hoff Venkat S. K. Balagurusamy Donna Dillenberger Elias Chaibub Neto Thea Norman Tero Aittokallio Muhammad Ammad-ud-din Chloé‐Agathe Azencott Víctor Bellón Valentina Boeva Kerstin Bunte Himanshu Chheda Lu Cheng Jukka Corander Michel Dumontier Anna Goldenberg Peddinti Gopalacharyulu Mohsen Hajiloo Daniel Hidru Alok Jaiswal Samuel Kaski Beyrem Khalfaoui Suleiman A. Khan Eric R. Kramer Pekka Marttinen Aziz M. Mezlini Bhuvan Molparia Matti Pirinen Janna Saarela Matthias Samwald Véronique Stoven Hao Tang Jing Tang Ali Torkamani Jean-Phillipe Vert Bo Wang Tao Wang Krister Wennerberg Nathan E. Wineinger Guanghua Xiao Yang Xie Rae S. M. Yeung Xiaowei Zhan Cheng Zhao Manuel Calaza Haitham Elmarakeby Lenwood S. Heath Quan Long Jonathan D. Moore Stephen O. Opiyo Richard S. Savage Jun Zhu Jeff Greenberg Joel Kremer Kaleb Michaud Anne Barton Marieke J. H. Coenen Xavier Mariette Corinne Miceli‐Richard Nancy A. Shadick Michael E. Weinblatt Niek de Vries Paul P. Tak Daniëlle M. Gerlag T. Huizinga Fina Kurreeman Cornelia F Allaart S. Louis Bridges Lindsey A. Criswell Larry W. Moreland Lars Klareskog Saedís Saevarsdóttir Leonid Padyukov Peter K. Gregersen Stephen Friend Robert Plenge Gustavo Stolovitzky Baldo Oliva Yuanfang Guan

Rheumatoid arthritis (RA) affects millions world-wide. While anti-TNF treatment is widely used to reduce disease progression, fails in ∼one-third of patients. No biomarker currently exists that identifies non-responders before treatment. A rigorous community-based assessment the utility SNP data for predicting efficacy RA patients was performed context a DREAM Challenge (http://www.synapse.org/RA_Challenge). An open challenge framework enabled comparative evaluation predictions developed by...

10.1038/ncomms12460 article EN cc-by Nature Communications 2016-08-23

519 Background: Approximately 4% of metastatic colorectal cancers (mCRCs) are associated with high microsatellite instability (MSI-H), indicating a deficient DNA mismatch repair (dMMR) system. dMMR/MSI-H CRC exhibits an increased tumor neoantigen load and immune cell infiltration is hypothesized to be targetable by checkpoint inhibitors. CheckMate 142 (NCT02060188) evaluates the efficacy safety nivolumab (nivo) in patients (pts) mCRC. Methods: Pts mCRC who progressed on/were intolerant ≥1...

10.1200/jco.2017.35.4_suppl.519 article EN Journal of Clinical Oncology 2017-02-01

Wearable sensors have garnered considerable interest from humans over the past decades owing to their broad application prospects and huge development potential. Yet limited number of reliable noninvasive wearable has greatly hindered progress in field health management. Because its good adaptability, physiology significance abundant biomarkers, oral cavity, as one ideal positions for monitoring using sensors, is suitable diverse biomedical applications. This paper presents a review...

10.1016/j.biosx.2022.100135 article EN cc-by-nc-nd Biosensors and Bioelectronics X 2022-03-27

Abstract Background Immune cells that infiltrate lesions are important for atherosclerosis progression and immunotherapies. This study was aimed at gaining new insights into the heterogeneity of these by integrating sequencing results multiple samples using an enhanced single-cell workflow to overcome limitations a single study. Results Integrative analyses identified 28 distinct subpopulations based on gene expression profiles. Further analysis demonstrated manifested high levels tissue...

10.1186/s12915-023-01540-2 article EN cc-by BMC Biology 2023-02-28
Coming Soon ...